Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ho

Showing results (1011-1020 of 1,367) with videos related to

Pageof 137
Sort By:
Structure (London, England : 1993)|September 10, 2003
The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domainJohn R Somoza, Joseph D Ho, Christine Luong, et al.
The Journal of Infectious Diseases|June 2, 1998
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infectionM Markowitz, M Conant, A Hurley, et al.
European Journal of Haematology|September 7, 2004
Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphomaEugen Leo, Lars Scheuer, Ingo G H Schmidt-Wolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapyA Schneeweiss, I Diel, M Hensel, et al.
Cancer|March 7, 2007
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisisStefan Fruehauf, Julian Topaly, Eike C Buss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2011
Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cellsSascha Dietrich, Oliver H Krämer, Esther Hahn, et al.
Transplantation|October 24, 2014
Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantationSascha Dietrich, Aleksandar Radujkovic, Friedrich Stölzel, et al.
Oncotarget|October 10, 2014
Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1Verena Wagner, Dirk Hose, Anja Seckinger, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 25, 2014
Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasoneTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2005
Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cellsDouglass Wu, Guo-Wen Xing, Michael A Poles, et al.
Pageof 137

Showing results (1011-1020 of 1,367) with videos related to

Sort By:
Pageof 137
Structure (London, England : 1993)|September 10, 2003
The structure of the extracellular region of human hepsin reveals a serine protease domain and a novel scavenger receptor cysteine-rich (SRCR) domainJohn R Somoza, Joseph D Ho, Christine Luong, et al.
The Journal of Infectious Diseases|June 2, 1998
A preliminary evaluation of nelfinavir mesylate, an inhibitor of human immunodeficiency virus (HIV)-1 protease, to treat HIV infectionM Markowitz, M Conant, A Hurley, et al.
European Journal of Haematology|September 7, 2004
Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphomaEugen Leo, Lars Scheuer, Ingo G H Schmidt-Wolf, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2004
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapyA Schneeweiss, I Diel, M Hensel, et al.
Cancer|March 7, 2007
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisisStefan Fruehauf, Julian Topaly, Eike C Buss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2011
Leflunomide induces apoptosis in fludarabine-resistant and clinically refractory CLL cellsSascha Dietrich, Oliver H Krämer, Esther Hahn, et al.
Transplantation|October 24, 2014
Pretransplant metabolic distress predicts relapse of acute myeloid leukemia after allogeneic stem cell transplantationSascha Dietrich, Aleksandar Radujkovic, Friedrich Stölzel, et al.
Oncotarget|October 10, 2014
Preclinical efficacy of sepantronium bromide (YM155) in multiple myeloma is conferred by down regulation of Mcl-1Verena Wagner, Dirk Hose, Anja Seckinger, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 25, 2014
Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasoneTilmann Bochtler, Ute Hegenbart, Christina Kunz, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 25, 2005
Bacterial glycolipids and analogs as antigens for CD1d-restricted NKT cellsDouglass Wu, Guo-Wen Xing, Michael A Poles, et al.
Pageof 137